Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes have?
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes has 55 citations in the OpenAlex counts ScholarIQ stores.
When was Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes published?
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes has 2023 year in the ScholarIQ index.
What is the open-access status of Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes?
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes has hybrid oa status in the ScholarIQ index.
What is the DOI of Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes?
The DOI for Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes is on the source record.
What is the PMID of Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes?
The PMID for Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes is on the source record.
What is the OpenAlex record for Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes?
The OpenAlex for Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes is on the source record.